I
QHQ's Innovation Park in Andover, Massachusetts has secured a long-term commitment from Generate:Biomedicines. The company, which sits at the intersection of machine learning, biological engineering, and medicine, will continue to advance its programmable biology platform at the site.

    Generate's 75,000 square foot CryoEM laboratory is one of the largest in the US, equipped with four state-of-the-art microscopes that produce vast amounts of data daily. This cutting-edge facility enables advancements in therapeutic design and discovery through The Generate Platform.

    "We're proud to have Generate:Biomedicines as a long-term partner at Innovation Park," said Tracy Murphy, Co-CEO and Co-Founder of IQHQ. "Our mission is to provide best-in-class ecosystems for leading life science companies, and we look forward to Generate's continued success."

    This deal follows IQHQ's recent $900 million capital raise in 2024, positioning the company to capitalize on opportunities in the improving life science market.